Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain protein I3 pseudogene 3 (BRI3P3) is a human pseudogene, not a protein-coding gene. Pseudogenes are DNA sequences similar to functional genes but are typically nonfunctional, often containing disabling mutations that prevent protein expression. Some pseudogenes can exert regulatory functions in the genome, such as acting as competing endogenous RNAs (ceRNAs) or decoys for microRNAs, but there is no specific evidence that BRI3P3 performs such roles. BRI3P3 does not encode a receptor, enzyme, transporter, or other classical therapeutic target class, and there are no drugs or direct disease associations definitively linked to it[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain protein I3 pseudogene 3 (BRI3P3).